We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

180 hedge funds and large institutions have $1.87B invested in Spectrum Pharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 73 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 17

94% more call options, than puts

Call options by funds: $20.1M | Put options by funds: $10.4M

78% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 41

42% more capital invested

Capital invested by funds: $1.32B → $1.87B (+$554M)

12% more funds holding

Funds holding: 161180 (+19)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
180
Holders Change
+19
Holders Change %
+11.8%
% of All Funds
4.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
73
Reduced
41
Closed
17
Calls
$20.1M
Puts
$10.4M
Net Calls
+$9.7M
Net Calls Change
+$15.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
51
ClariVest Asset Management
California
$3.12M -$1.32M -71,021 -32%
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$3.02M -$481K -25,990 -15%
SCM
53
Sio Capital Management
New York
$3.01M +$2.66M +143,550 New
PPA
54
Parametric Portfolio Associates
Washington
$2.9M +$190K +10,278 +8%
ASRS
55
Arizona State Retirement System
Arizona
$2.86M -$124K -6,687 -5%
GC
56
Guggenheim Capital
Illinois
$2.83M +$90.2K +4,868 +4%
New York State Teachers Retirement System (NYSTRS)
57
New York State Teachers Retirement System (NYSTRS)
New York
$2.82M +$24.5K +1,321 +1%
Canada Life
58
Canada Life
Manitoba, Canada
$2.46M +$15.3K +828 +0.7%
Barclays
59
Barclays
United Kingdom
$2.38M -$17.9M -965,493 -89%
Comerica Bank
60
Comerica Bank
Texas
$2.35M +$30.3K +1,634 +2%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$2.31M +$272K +14,700 +15%
CS
62
Credit Suisse
Switzerland
$2.16M -$415K -22,377 -18%
State of Wisconsin Investment Board
63
State of Wisconsin Investment Board
Wisconsin
$2.12M +$248K +13,400 +15%
Squarepoint
64
Squarepoint
New York
$2.06M +$1.82M +98,507 New
SEC
65
Seven Eight Capital
New York
$1.98M +$1.75M +94,653 New
3C
66
361 Capital
Colorado
$1.96M +$1.73M +93,561 New
CAM
67
Congress Asset Management
Massachusetts
$1.81M +$866K +46,770 +117%
AIG
68
American International Group
New York
$1.59M +$372K +20,106 +36%
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.55M +$166K +8,953 +14%
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
$1.48M +$1.31M +70,755 New
DekaBank Deutsche Girozentrale
71
DekaBank Deutsche Girozentrale
Germany
$1.47M
MAP
72
Moody Aldrich Partners
Massachusetts
$1.39M +$1.23M +66,498 New
QOP
73
Quinn Opportunity Partners
Virginia
$1.38M +$1.22M +66,000 New
PI
74
PineBridge Investments
New York
$1.36M -$54K -2,917 -4%
Thrivent Financial for Lutherans
75
Thrivent Financial for Lutherans
Minnesota
$1.35M +$97K +5,234 +9%

SPPI Hedge Fund Activity: Q2 2018 in Review

180 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2018, worth a combined $1.87B — up 42% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new SPPI positions and 17 closed out — a net gain of 20 holders — while 73 added to existing stakes and 41 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $63.4M. The largest seller was Renaissance Technologies, cutting an estimated $38.2M.

  • 180 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2018, up from 161 in Q1 2018.
  • Funds reported $1.87B of Spectrum Pharmaceuticals Inc stock for Q2 2018, up 42% quarter-over-quarter.
  • 37 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2018 and 17 closed out, a net change of +20 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2018 was Avoro Capital Advisors, an estimated $63.4M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2018 was Renaissance Technologies, an estimated $38.2M sold.

Based on aggregated 13F filings for Q2 2018.